This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Tony Oro: Innovator in Genetic Diagnostics
Introduction
Tony Oro is a prominent inventor based in Palo Alto, California. He has made significant contributions to the field of genetics, particularly in the area of cancer diagnostics. His work focuses on the patched gene, which plays a crucial role in understanding genetic predispositions to certain cancers.
Latest Patents
Tony Oro holds a patent for "Patched genes and their use for diagnostics." This patent outlines methods for isolating patched genes, including those from mammals such as mice and humans, as well as invertebrate patched genes and sequences. The loss of function of the patched gene is associated with the occurrence of human cancers, particularly basal cell carcinomas of the skin. His research highlights the importance of using the patched gene as a diagnostic tool for assessing genetic predispositions to cancer and identifying specific cancers with mutations in this gene. He has 1 patent to his name.
Career Highlights
Tony Oro is affiliated with the University of California, where he continues to advance research in genetic diagnostics. His work has implications for both familial and sporadic forms of cancer, providing valuable insights into the genetic factors that contribute to these diseases.
Collaborations
Tony has collaborated with notable colleagues, including Ervin H Epstein, Jr. and Matthew Peter Scott. Their combined expertise enhances the research efforts in the field of genetics and cancer diagnostics.
Conclusion
Tony Oro's innovative work in the field of genetic diagnostics has the potential to significantly impact cancer detection and treatment. His contributions to understanding the patched gene are vital for advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
